Free Trial

Fresenius Medical Care (ETR:FME) Shares Cross Above Two Hundred Day Moving Average - Should You Sell?

Fresenius Medical Care logo with Medical background

Shares of Fresenius Medical Care AG (ETR:FME - Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of €46.12 ($54.26) and traded as high as €48.09 ($56.58). Fresenius Medical Care shares last traded at €47.88 ($56.33), with a volume of 400,299 shares trading hands.

Fresenius Medical Care Stock Performance

The company has a market cap of $14.12 billion, a price-to-earnings ratio of 21.44, a P/E/G ratio of 0.42 and a beta of 0.86. The company has a current ratio of 1.37, a quick ratio of 0.80 and a debt-to-equity ratio of 82.24. The stock's fifty day simple moving average is €49.01 and its 200 day simple moving average is €46.13.

About Fresenius Medical Care

(Get Free Report)

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Recommended Stories

Should You Invest $1,000 in Fresenius Medical Care Right Now?

Before you consider Fresenius Medical Care, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fresenius Medical Care wasn't on the list.

While Fresenius Medical Care currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Made in America Stocks Under $20 You Need to See!
3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines